Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Arndt Katzenwadel"'
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Methadone has beneficial characteristics as an analgesic against cancer pain, including high bioavailability, multiple receptor affinities, and lack of active metabolites that might induce adverse side effects. However, methadone has an own pharmacol
Externí odkaz:
https://doaj.org/article/ee1e0c0f324645b18e28978d85540f25
Publikováno v:
Der Urologe. 60:732-739
Bei der urologischen Implantatchirurgie im Bereich der erektilen Dysfunktion und der Belastungsharninkontinenz spielt fur den spateren Behandlungserfolg die richtige Patientenselektion eine entscheidende Rolle. Durch eine leitliniengerechte Indikatio
Publikováno v:
Der Urologe. 60:178-185
The following article summarizes the current evidence including postoperative success rates and complications for various surgical options in the treatment of urinary incontinence. Due to different inclusion criteria and inconsistent definitions of s
Autor:
Maria Cazana, Johannes Spaeth, Arkadiusz Miernik, Daniel Schlager, Martin Schoenthaler, Arndt Katzenwadel, Dominik S. Schöb, Ulrich Wetterauer, Anja Reichelt, Konrad Wilhelm, Simon Hein
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 26:50-55
Auch wenn die transurethrale Resektion der Prostata (TURP) den Goldstandard in der chirurgischen Behandlung der symptomatischen Prostatahyperplasie bei kleinen Prostatadrusen darstellt, werden derzeit bei Prostatavolumina >70–80 cm3 aufgrund des ho
Autor:
R. Anding, Hagen Loertzer, Markus Grabbert, Torben Hofmann, Ricarda M. Bauer, Tobias Pottek, Christian Gratzke, Fabian Queissert, Ruth Kirschner-Hermanns, A. Haferkamp, T. Huesch, Carsten Maik Naumann, Wilhelm Huebner, A. Kretschmer, Arndt Katzenwadel, Roland Homberg, Wael Khoder
Publikováno v:
European Urology. 79:S157
Publikováno v:
Anticancer research. 38(3)
Background Cisplatin-based chemotherapy is the treatment of choice for advanced bladder cancer. Since many tumor cells show inherent or acquired cisplatin resistance, research is needed to improve the therapeutic efficacy. Since the analgesic methado
Autor:
Konrad Wilhelm, Arndt Katzenwadel, Ioana Maria Cazana, Johannes Spaeth, Arkadiusz Miernik, Martin Schoenthaler
Publikováno v:
World Journal of Urology
Purpose To evaluate long-term efficacy and safety of low-pressure transurethral resection of the prostate for prostates 70 cc (group 2). Patients and methods In this study patients operated with monopolar TURP between 2009 and 2012 were evaluated ret
Autor:
Philipp Wolf, Arndt Katzenwadel, Patrick Bühler, Karen Alt, Ursula Elsässer-Beile, David Wetterauer, Ulrich Wetterauer, Dorothee Gierschner
Publikováno v:
Journal of Immunotherapy. 33:262-271
The prostate-specific membrane antigen (PSMA) is abundantly expressed on prostate cancer epithelial cells and its expression correlates with tumor progression. Therefore, a specific immunotherapy against this antigen may be a novel therapeutic option
Autor:
Wolfgang W. A. Schamel, Wolfgang Schultze-Seemann, Arndt Katzenwadel, I. Schaber, Mahima Swamy, Philipp Wolf, Patrick Bühler, Dorothee Gierschner, Marlene Tacke, Ursula Elsässer-Beile, Ulrich Wetterauer
Publikováno v:
Cancer Immunology, Immunotherapy
Background Although cancer of the prostate is one of the most commonly diagnosed cancers in men, no curative treatment currently exists after its progression beyond resectable boundaries. Therefore, new agents for targeted treatment strategies are ne
Autor:
Ursula Elsässer-Beile, Arndt Katzenwadel, Patrick Bühler, Philipp Wolf, Karen Alt, Marlene Tacke, Ulrich Wetterauer
Publikováno v:
The Prostate. 68:129-138
BACKGROUND Expression of the prostate specific membrane antigen (PSMA) is highly restricted to prostate epithelial cells. Therefore, toxin-based immunotherapy against this antigen may represent an alternative therapeutic option for prostate cancer. F